GCNT1 and hepatocellular carcinoma: Our findings are novel because they indicate that targeting of the C2GnT1 gene and subsequent down-regulation of C2-O-sLeX expression, a selectin ligand on colon and hepatic carcinoma cells, altered key properties of metastasis that are likely occur in vivo: decreased attachment of circulating tumor cells to endothelium and invasion into tissues.